Evidence map›Paper›PMID 42769632›Full record

ArticleCureus2026

Hereditary Elliptocytosis Identified During the Evaluation of Splenomegaly: A Case Report.

Bonaventure Oguaju, Marlene Hamilton, Lindsay Bridgland

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Bonaventure OguajuGeneral Internal Medicine, University of Alberta, Edmonton, CAN.
Marlene HamiltonHematology, University of Alberta, Edmonton, CAN.
Lindsay BridglandGeneral Internal Medicine, University of Alberta, Edmonton, CAN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary elliptocytosis (HE) is a red blood cell (RBC) membrane disorder resulting from a mutation in RBC membrane proteins that predispose the cell to hemolysis. Clinical presentation can range from patients being asymptomatic to hemolysis with splenomegaly and anemia. In this report, we present the case of a 40-year-old female with a history of intermittent normocytic normochromic anemia and chronic left upper abdominal pain with mild splenomegaly. During workup for splenomegaly, she was found to have elliptocytes on her blood smear, leading to a clinical diagnosis of HE. For individuals diagnosed with asymptomatic HE, the management focus should be on counseling about the condition, including education on the complications associated with HE.

Indexed as

anemiahereditary elliptocytosisjaundicemcvsplenomegaly

Identifiers

PMID42769632
PMCPMC13592014

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.